IMAX’s (IMAX) Buy Rating Reaffirmed at Rosenblatt Securities
IMAX (NYSE:IMAX – Get Free Report)‘s stock had its “buy” rating reiterated by equities research analysts at Rosenblatt Securities in a research note issued on Thursday,Benzinga reports. They presently have a $35.00 price objective on the stock. Rosenblatt Securities’ price objective would suggest a potential upside of 46.50% from the stock’s previous close. Several other […]
